K211136: VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K211136 (VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML), cleared 2021-06-14 for bioMerieux, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K211136
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK211136
Cleared Device Trade / Generic NameVITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML)
FDA Applicant on FilingbioMerieux, Inc.
FDA 3-Letter Product ClassificationProduct Code LON
FDA Substantial Equivalence Decision Date2021-06-14
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at bioMerieux, Inc., compare peer devices under FDA Product Code LON, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.